Maksim N. Morgunov

Maksim N. Morgunov

Auto-generated profile, based on publicly available information

Maksim N. Morgunov

Rostov State Medical University

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2025 in South Russian Journal of Therapeutic Practice
Verified
Journal Article
Open access
PDF file
ISI. F. Shlyk
I. F. Shlyk
IAI. I. Andreeva
I. I. Andreeva
MMM. N. Morgunov
M. N. Morgunov
MKM. V. Kharitonova
M. V. Kharitonova
DBD. Yu. Besedina
D. Yu. Besedina
Objective: to study the cytokine profile in patients with coronary calcification of varying severity, without clinical manifestations of coronary artery disease. Materials and methods: the study included 68 male patients matched for age, including 25 people with coronary atherocalcinosis — corresponding to the moderate-risk group (group 1), 23 people with coronary atherocalcinosis — corresponding to the high-risk group (group 2) and 20 respondents of the control group, without clinical manifestations of coronary artery disease, for whom the coronary index was calculated using the Agatston method. Exclusion criteria were: diabetes mellitus, oncopathology, connective tissue diseases, chronic viral infections. Coronary calcium (CC) assessment and Agatston index calculation were performed using Smart Score software for coronary calcium calculation. Serum cytokine levels (IL-4, IL-6, IL-10, IL-17, FNO-α and IFN-γ) were measured using enzyme-linked immunosorbent assay (ELISA) with Cytokine test systems from Cytokin LLC, St. Petersburg, Russia. Statistical analysis of the study results was performed using Statistica 12.0 (StatSoft, USA). Results: elevated proinflammatory cytokine values were detected in both coronary calcification groups. Assessment of proinflammatory to antiinflammatory cytokine ratio indices reflects polarization of the cytokine profile in patients with coronary calcification via the proinflammatory pathway and prevalence of anti-inflammatory reserve in patients with less severe coronary artery calcification. Conclusion: a comprehensive assessment of the cytokine profile in patients with varying degrees of coronary calcification without clinical manifestations of coronary artery disease is demonstrated, showing the predominance of the proinflammatory response in both groups while maintaining suppressive immunoregulatory effects in patients with less pronounced coronary calcification. The data obtained are not unambiguous due to the peculiarities of the pleiotropic effect of cytokines, which requires a comparison of the results with quantitative and functional indicators of immunocompetent cells responsible for their synthesis.

18 October 2025 in Primary Health Care (Russian Federation)
Verified
Journal Article
Open access
PDF file
ISI. F. Shlyk
I. F. Shlyk
MMM. N. Morgunov
M. N. Morgunov
MKM. V. Kharitonova
M. V. Kharitonova
DBD. Yu. Besedina
D. Yu. Besedina
Aim. To assess comorbidities in patients with varying coronary calcification who visited a general practitioner. Material and methods. The study included patients without a confirmed diagnosis of coronary artery disease (CAD) but with its risk factors. All patients underwent a pre-test assessment of CAD probability. The study included a total of 100 patients, in which an Agatston score was assessed using multislice computed tomography (MSCT) and the SmartScore software application. Patients without coronary artery calcification and with an Agatston index <11 were excluded. Of the 59 participants, three following groups were formed: group 1 — coronary calcium score 11- 100 (n=19), group 2 — 101-400 (n=20), group 3 — ≥401 U (n=20). Results. In the formed groups n=19/20/20, the following were established: mean age (M±m, years): 60,7±1,4; 63,3±1,3; 67,2±1,03, coronary calcification score (M±m, U): 44,8±4,8; 294,4±18,1; 715,8±25,9 and pre-test CAD probability (M±m, %): 16,3±1,3; 17,3±1,2; 21,2±1,8, respectively. There was following distribution of comorbidities in the groups (n/%): chronic obstructive pulmonary disease (COPD): 4/21,1; 3/15,0; 9/45,0; type 2 diabetes (T2D): 7/36,8; 4/20,0; 5/25,0; asthma: 3/15,8; 7/35,0; 3/15,0; no COPD/asthma/T2D: 5/26,3%; 6/30,0%; 3/15,0%, respectively. Conclusion. When conducting screening measures and assessing the pre-test CAD probability, COPD and asthma should be carefully identified, and, if present, CCS should be studied.

28 April 2024 in Innovative Medicine of Kuban
Verified
Journal Article
Open access
PDF file
NNN. J. Nelasov
N. J. Nelasov
TKT. A. Karkoshka
T. A. Karkoshka
OEO. L. Eroshenko
O. L. Eroshenko
MMM. N. Morgunov
M. N. Morgunov
APA. I. Paleniy
A. I. Paleniy
Objective: To study the diagnostic efficiency (DE) of sonographic signs in differentiation of inflammatory bowel disease (IBD) and functional bowel disorder (FBD) in children and to develop an optimal mathematical model for differential diagnosis of IBD and FBD using comprehensive assessment of sonographic signs.Material and methods: We examined 79 children with and without clinical signs of large-bowel disease. All the children underwent bowel ultrasonography with strain elastography. We also determined the level of fecal calprotectin (FC). The FC level > 120 μg/g was a cutoff value to differentiate IBD from FBD.Results: We determined the DE of sonographic signs in verification of IBD and FBD: large-bowel wall thickening (DE, 87%; P < .0001), large-bowel wall stratification (DE, 93.1%; P < .0001), enlarged mesenteric lymph nodes (DE, 53.4%; P=.591), interloop ascites (DE, 98.3%; P < .0001), Color Doppler findings in the large-bowel wall (DE, 98.3%; P < .0001), strain elastography findings in the large-bowel wall (DE, 96.5%; P < .0001). We developed an optimal model for differentiation of FBD and IBD using the analysis of sonographic signs (DE, 98.7%).Conclusions: The sonographic signs (large-bowel wall thickening, large-bowel wall stratification, interloop ascites, color Doppler findings in the large-bowel wall, stiffness found on strain elastography) can be effectively used for differential diagnosis of FBD and IBD in children. The developed mathematical model enables to reliably differentiate children with FBD and IBD.

17 October 2024 in Medical Herald of the South of Russia
Verified
Journal Article
Open access
PDF file
ISI. F. Shlyk
I. F. Shlyk
MKM. V. Kharitonova
M. V. Kharitonova
MMM. N. Morgunov
M. N. Morgunov
IBI. M. Blinov
I. M. Blinov
EVE. D. Vasilyeva
E. D. Vasilyeva
DBD. Yu. Besedina
D. Yu. Besedina
The presented literature review allows us to understand and supplement the existing ideas about the pathogenesis of coronary calcification and aortic valve calcification at the stage of formation of these changes. To study in detail the participation of the most studied immunocompetent cells of innate immunity, such as macrophages, dendritic and mast cells, neutrophils, natural killers in calcification of arteries and aortic valve, their functional role in the progression of this process. The review also presents gaps and missing data present in the study of these cell populations, the replenishment of which will contribute to the development of targeted therapy for the calcification process.The search for literature sources was conducted in the following databases: Scopus, web of Science, MedLine, The Cochrane Library, RSCI, Springer, Science Direct — taking into account the year of publication (no more than 10 years), language of publication (English/Russian), availability of full-text publications and access to them.

30 September 2026 in I.P. Pavlov Russian Medical Biological Herald
Verified
Journal Article
Closed access
PDF file
ISIrina F. Shlyk
Irina F. Shlyk
ШФШлык Ирина Федоровна
Шлык Ирина Федоровна
VZVita Ya. Zakurskaya
Vita Ya. Zakurskaya
ЗЯЗакурская Вита Яковлевна
Закурская Вита Яковлевна
MMMaksim N. Morgunov
Maksim N. Morgunov
БЮБеседина Дарья Юрьевна
Беседина Дарья Юрьевна
BACKGROUND: Coronary heart disease (CHD) is the leading cause of mortality among diseases of the circulatory system. Early identification of CHD facilitates timely diagnosis and reduces mortality. The initial assessment during a physician's visit is the pretest probability (PTP) of CHD, which lacks high sensitivity and specificity. Therefore, determining the prognostic value of additional, clarifying examination methods is important. AIM: To evaluate the diagnostic sensitivity and specificity of the Agatston score and left ventricular Global Longitudinal Strain average (GLSavg) for identifying hemodynamically significant coronary artery stenosis in patients with PTP of CHD between 5% and 15%. METHODS: A cross-sectional cohort study of patients (n=95) of both sexes (more than 57% to men and more than 42% to women) aged 45–65 years, meeting inclusion criteria (signed informed consent for participation in the study and a PTP value of 5–15%) was conducted in 2024–2025. RESULTS: The main comorbidities were arterial hypertension and/or dyslipidemia. The Agatston score was 344 [95; 652] units, GLSavg was -18 [-20;-15]%. Hemodynamically significant coronary artery stenosis was detected in 50.5% of cases. The cut-off point for the Agatston score was 120 units; diagnostic sensitivity: 96.55%, specificity: 55.56%; area under the ROC curve: 0.746±0.072 (95% confidence interval 0.612–0.853, z=3.421, p=0.0061). The cut-off point for GLSavg was -18%; diagnostic sensitivity: 93.10%, specificity: 77.78%; area under the ROC curve: 0.945±0.026 (95% confidence interval 0.849–0.988, z=16.769, p=0.00012). CONCLUSION: Based on the study results, the cut-off values for the Agatston score and GLSavg, as well as their sensitivity and specificity, were determined. Despite certain limitations of the study (sample size), these values allow for clarifying the indications for coronary angiography.

17 November 2020 in Journal of radiology and nuclear medicine
Verified
Journal Article
Open access
PDF file
NNN. Yu. Nelassov
N. Yu. Nelassov
MMM. N. Morgunov
M. N. Morgunov
RSR. V. Sidorov
R. V. Sidorov
NDN. S. Doltmurzieva
N. S. Doltmurzieva
OEO. L. Eroshenko
O. L. Eroshenko
SSS. V. Shlyk
S. V. Shlyk
Новый алгоритм стресс-эхокардиографии с аденозинтрифосфатом